Our Partnerships with Governments and Associations
Our Experience Partnering with the Foundation for the National Institutes of Health (FNIH)
Ultromics was thrilled to join The Accelerating Medicines Partnership® Heart Failure (AMP® HF) as a full partner. We are working alongside the National Institutes of Health (NIH) and the National Heart Lung and Blood Institute (NHLBI), managed by FNIH, to investigate heart failure with preserved ejection fraction (HFpEF).
“The FNIH will harness valuable perspectives and expertise of a select number of collaborations, including Ultromics, to alleviate this unmet need and pave the way for better classification and more precise treatment strategies.” said Dr. Julie Gerberding, Chief Executive Officer at the FNIH.
“The FNIH will harness valuable perspectives and expertise of a select number of collaborations, including Ultromics, to alleviate this unmet need and pave the way for better classification and more precise treatment strategies.”
Partnering with the American Society of Echocardiography
The American Society of Echocardiography (ASE) is the largest global organization of professionals seeking to advance cardiovascular ultrasound. Their mission has been to improve lives through excellence in education, research, innovation, advocacy, and service to both the professional and public sectors.
We are proud to have joined the ASE as an industry roundtable partner. This partnership between practitioners, scientists, and industry representatives advocates for outcomes-driven innovations in the field of echocardiography by fostering the development of high-quality technology and products.
Our partnership has led us to play a key role in research by the World Alliance Societies of Echocardiography (WASE), led by the ASE, to implement and test AI during the COVID-19 pandemic.
We continue to present our newest findings and innovations at the ASE’s annual Scientific Sessions.
“Knowing we had to move quickly to figure out if there was anything about heart health that we could associate with COVID-19 outcomes, we were motivated to secure an industry partner to help accelerate our analysis timeline. Using Ultromics' software to anonymize echocardiograms, upload them to a cloud platform, and use artificial intelligence to quickly and accurately analyze each exam was hugely beneficial in bringing this report forward while the world is still fighting this virus.”
